S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report

BACKGROUND: Neuroendocrine carcinoma of the breast (NECB) is a rare type of malignant tumor. Due to the rarity of NECB, the relevant literature mostly comprises case reports. Available data on treatment options for NECB are very limited. CASE SUMMARY: A 62-year-old woman presented to our hospital in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Shi, Yan-Fen, Duan, Jiang-Hui, Wang, Chao, Tan, Huang-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409205/
https://www.ncbi.nlm.nih.gov/pubmed/34540971
http://dx.doi.org/10.12998/wjcc.v9.i24.7146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409205/
https://www.ncbi.nlm.nih.gov/pubmed/34540971
http://dx.doi.org/10.12998/wjcc.v9.i24.7146

Ejemplares similares